treosulfan (Pending FDA Approval)

Brand and Other Names:

Dosing & Uses

Allogenic-HSCT Conditioning

Pending FDA approval for allogenic hematopoietic stem cell transplantation (HSCT) conditioning in combination with fludarabine

Next:

Pharmacology

Mechanism of Action

Prodrug of sulfonate alkylating agent that elicits myeloablative, immunosuppressive, and antineoplastic activities

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.